<DOC>
	<DOCNO>NCT01510145</DOCNO>
	<brief_summary>The purpose study assess efficacy tolerability TRAVATAN速 solution without BAK ( benzalkonium chloride ) change prior latanoprost 0.005 % ophthalmic solution monotherapy subject open-angle glaucoma ocular hypertension due tolerability issue .</brief_summary>
	<brief_title>Efficacy Changing TRAVATAN速 From Prior Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Clinical diagnosis ocular hypertension openangle glaucoma least one eye ; On latanoprost ophthalmic solution 0.005 % monotherapy ( include BAKcontaining generic ) least 4 week prior Screening Visit , would benefit switch TRAVATAN速 BAKfree tolerability issue , opinion investigator ; Intraocular pressure ( IOP ) &lt; 30 millimeter mercury ( mmHg ) eye latanoprost ophthalmic solution 0.005 % monotherapy ; IOP consider safe ( opinion investigator ) , eye , way assure clinical stability vision optic nerve throughout study period ; Willing discontinue use ocular hypotensive medication prior receive study medication entire course study ; Able follow instruction willing able attend study visit ; Best correct Snellen visual acuity 6/60 ( 20/200 ; 1.0 LogMAR ) good eye ; Must sign inform consent form ; Other protocoldefined inclusion criterion may apply . Known medical history allergy , hypersensitivity , poor tolerance component preparation use study deem clinically significant opinion Principal Investigator ; Any abnormality prevent reliable applanation tonometry either eye ; Corneal dystrophies either eye ; Concurrent infectious/noninfectious conjunctivitis , keratitis uveitis either eye ; Any clinically significant , serious , severe medical condition ; Use systemic medication know affect IOP stable course least 7 day prior Screening Visit anticipated change dosage course study ; Severe dry eye keratoconjunctivitis sicca currently treat use punctal plug , punctal cautery , Restasis速 , topical ocular corticosteroid ; Intraocular conventional surgery laser surgery either eye le 3 month prior Screening Visit ; Risk visual field visual acuity worsen consequence participation study , investigator 's best judgment ; Progressive retinal optic nerve disease cause ; Women pregnant , lactating , use reliable mean birth control ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Open-angle glaucoma</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Eye Diseases</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Travoprost</keyword>
	<keyword>Antihypertensive Agents</keyword>
	<keyword>Cardiovascular Agents</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Pharmacologic Actions</keyword>
</DOC>